Laparoscopic Magnetic Sphincter Augmentation: Potential Applications and Safety Are Becoming More Clear—But the Story Is Not Over

Gastroesophageal reflux disease (GERD) affects more than 20% of the US population and is the second most common gastrointestinal (GI) diagnosis in an outpatient setting, and medication cost in 2015 was estimated at nearly $13 billion (9.1% of health care costs).1Peery A.F. Crockett S.D. Murphy C.C. et al.Burden and cost of gastrointestinal, liver and pancreatic diseases in the United States: update 2018.Gastroenterology. 2019; 156:...